HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Continuous hemodiafiltration in the treatment of reactive hemophagocytic syndrome refractory to medical therapy.

Abstract
Reactive (or secondary) hemophagocytic syndrome (RHS) is a potentially lethal condition and characterized by hypercytokinemia. Immune modulating drugs sometimes fail to achieve satisfactory control. Therefore we investigate the efficacy of continuous hemodiafiltration using a polymethyl methacrylate membrane hemofilter (PMMA-CHDF) for cytokine removal in patients with RHS. Eight consecutive patients who admitted to our ICU with RHS complicating organ failures and refractory to medical therapy were initiated intensive care including PMMA-CHDF. Although remission was achieved in six patients, remaining two patients died of exacerbation of underlying diseases. Changes in blood levels of tumor necrosis factor alpha (TNF-alpha) and interleukin 6 (IL-6) as indices of cytokine network activation, and serum ferritin level as an index of severity of RHS were investigated during PMMA-CHDF. PMMA-CHDF performed for 3 days significantly reduced blood TNF-alpha level (183+/-159 pg/ml to 84+/-98 pg/ml, p<0.05) and also blood IL-6 level (1113+/-903 pg/ml to 402+/-411 pg/ml, p<0.01). Furthermore, serum ferritin level was significantly decreased 3 days after initiation of PMMA-CHDF (52390+/-65168 ng/ml to 4136+/-2932 ng/ml, p<0.05) although it tended to increase before initiation of PMMA-CHDF. No PMMA-CHDF-related adverse events were observed in any of the patients. PMMA-CHDF was effective to remove cytokine and improved disease severity. Thus, PMMA-CHDF may be an adjunctive treatment in RHS refractory to medical therapy.
AuthorsYoshihisa Tateishi, Shigeto Oda, Tomohito Sadahiro, Masataka Nakamura, You Hirayama, Ryuzo Abe, Hiroyuki Hirasawa
JournalTransfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis (Transfus Apher Sci) Vol. 40 Issue 1 Pg. 33-40 (Feb 2009) ISSN: 1473-0502 [Print] England
PMID19097821 (Publication Type: Journal Article)
Chemical References
  • Cytokines
  • Inflammation Mediators
  • Membranes, Artificial
  • Polymethyl Methacrylate
Topics
  • Adolescent
  • Adult
  • Child, Preschool
  • Critical Care
  • Cytokines (blood)
  • Female
  • Hemodiafiltration
  • Humans
  • Infant, Newborn
  • Inflammation Mediators (blood)
  • Lymphohistiocytosis, Hemophagocytic (blood, therapy)
  • Male
  • Membranes, Artificial
  • Middle Aged
  • Polymethyl Methacrylate
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: